Pharmathen is focused on developing complex
pharmaceuticals designed to improve patient compliance. Founded in 1969,
Pharmathen has grown to become one of the largest, vertically integrated
developers of innovative complex drug delivery technologies and generics
molecules. The company identifies and develops its own pipeline, owns its IP,
and through long term contracts out-licenses this IP to customers who in turn
market and sell the products. Pharmathen’s products have been licensed and approved in more than 95 countries
and sold to over 250 companies worldwide, throughout Europe, the Middle East, LATAM,
Asia, Australia, Southern Africa, and the United States. Building on
a portfolio of over 100 products, today Pharmathen is working on one of the
most extensive and advanced pipelines in Long Acting Injectables, Sustained
Release formulations, and Preservative Free Ophthalmics, produced in its FDA
and EU approved facilities!
Related Categories
Sales Markets
Western Europe; Eastern Europe; Middle East; Asia; North America; Central/South America
Meet us at
CPhI Worldwide 2021
Fiera Milano, Milan, Italy
9-11 November 2021
Book a meetingView Our Exhibitor Profile
Are you a supplier?
Here's what CPhI Online can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation